9 Jun 2009 11:36
e-Therapeutics plc
('ETX' or 'the Company')
CHANGE TO DIRECTOR'S DETAILS
Pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies, Dr Royston Drucker (Chief Medical Officer of the Company) has become aware that Technomark Consulting Services Limited, a company of which he was a non-executive director until his resignation on 08 June 2007, entered a company voluntary arrangement on 17 March 2008.
Dr Royston Drucker has no further details at this time.
For further information please contact:
e-Therapeutics plc | www.etherapeutics.co.uk |
Malcolm Young | +44 (0) 191 233 1317 |
Nominated Adviser | |
WH Ireland Limited | +44 (0) 161 832 2174 |
Katy Mitchell | |
Broker | |
Cornhill Asset Management | +44 (0) 207 645 8327 |
Tom Whitehead | |
Media enquiries | |
Abchurch | |
Heather Salmond | +44 (0) 207 398 7704 |
Stephanie Cuthbert | +44 (0) 207 398 7718 |
Simone Alves | +44 (0) 207 398 7728 |